Security key
682310875
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)
CUSIP: 682310875
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 109,272,143
- Total 13F shares
- 800,773
- Share change
- -397,791
- Total reported value
- $2,085,599
- Price per share
- $2.60
- Number of holders
- 28
- Value change
- -$679,945
- Number of buys
- 9
- Number of sells
- 13
Report period
Q2 2023
Institutions
28
Top holders
10
ONCY full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 682310875
Recent filing periods:
Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.22%
|
238,082
|
$285,524 | — | 31 Mar 2023 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
188,623
|
$226,348 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
129,856
|
$156,000 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
106,985
|
$128,382 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
87,858
|
$105,429 | — | 31 Mar 2023 | |
| CIBC WORLD MARKET INC. |
13F
|
Company |
0.06%
|
61,081
|
$75,000 | — | 31 Mar 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.05%
|
53,656
|
$64,000 | — | 31 Mar 2023 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.04%
|
40,000
|
$48,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
34,659
|
$41,590 | — | 31 Mar 2023 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.03%
|
34,506
|
$51,572 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
33,485
|
$40,182 | — | 31 Mar 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
22,918
|
$28,000 | — | 31 Mar 2023 | |
| Newman Dignan & Sheerar, Inc. |
13F
|
Company |
0.02%
|
18,915
|
$22,698 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
16,017
|
$19,000 | — | 31 Mar 2023 | |
| Cantonale Vaudoise Banque |
13F
|
Individual |
0.01%
|
11,900
|
$14,000 | — | 31 Mar 2023 | |
| Simplicity Solutions, LLC |
13F
|
Company |
0.01%
|
11,588
|
$13,906 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
9,150
|
$10,979 | — | 31 Mar 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
7,776
|
$9,331 | — | 31 Mar 2023 | |
| Cedar Mountain Advisors, LLC |
13F
|
Company |
0.01%
|
5,651
|
$6,781 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
5,300
|
$6,360 | — | 31 Mar 2023 | |
| Disciplined Investments, LLC |
13F
|
Company |
0%
|
5,189
|
$6,227 | — | 31 Mar 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
4,644
|
$5,561 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4,007
|
$4,808 | — | 31 Mar 2023 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
3,508
|
$4,204 | — | 31 Mar 2023 | |
| NewSquare Capital LLC |
13F
|
Company |
0%
|
1,220
|
$1,464 | — | 31 Mar 2023 | |
| SITTNER & NELSON, LLC |
13F
|
Company |
0%
|
1,000
|
$1,219 | — | 31 Mar 2023 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
557
|
$880 | — | 31 Mar 2023 | |
| JNBA Financial Advisors |
13F
|
Company |
0%
|
210
|
$252 | — | 31 Mar 2023 | |
| Advisory Services Network, LLC |
13F
|
Company |
0%
|
100
|
$120 | — | 31 Mar 2023 | |
| Cypress Capital Management LLC (WY) |
13F
|
Company |
0%
|
100
|
$120 | — | 31 Mar 2023 | |
| WOLFF WIESE MAGANA LLC |
13F
|
Company |
0%
|
31
|
$38 | — | 31 Mar 2023 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0%
|
5
|
$6 | — | 31 Mar 2023 |
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2023
As of 30 Jun 2023,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
800,773 shares.
The largest 10 holders included
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SNC, CIBC WORLD MARKET INC., Royal Bank of Canada, Long Focus Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, BANK OF MONTREAL /CAN/, and Newman Dignan & Sheerar, Inc..
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
30
Q2 2023 holders
28
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.